Cited by 1,492Cancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Open access

Tie, Jeanne, Wang, Yuxuan, Tomasetti, Cristian, Li, Lu, Springer, Simeon, Kinde, Isaac, Silliman, Natalie, Tacey, Mark, Wong, Hui-Li, Christie, Michael, Kosmider, Suzanne, Skinner, Iain, Wong, Rachel, Steel, Malcolm, Tran, Ben, Desai, Jayesh, Jones, Ian, Haydon, Andrew, Hayes, Theresa, Price, Tim J., Strausberg, Robert L., Diaz, Luis A., Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter·2016·Science Translational Medicine

DOI 10.1126/scitranslmed.aaf6219PMC PMC5346159

Open this paper in CoChat — free account

Abstract

Detection of circulating tumor DNA in patients with resected stage II colon cancer provides evidence of residual disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaf6219

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citation
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Self-citation
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746
Self-citation
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Self-citation
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623

Show all 43 references

Research works printed but not linked: 1

S. Edge D. R. Byrd C. C. Compton A. G. Fritz F. L. Greene A. Trotti AJCC Cancer Staging Manual (Springer New York 2010) 648 pp.

Sorted by citations

Items 801–900 of 1,001

Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas
Korte, B., & Mathios, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084195 · Cited by 11
Analysis of urine cell-free DNA in bladder cancer diagnosis by emerging bioactive technologies and materials
Huang, F., Di, X.-F., & Bai, M.-H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1458362 · Cited by 11
Multimodal Framework in Lung Cancer Management: Integrating Liquid Biopsy with Traditional Diagnostic Techniques
Qi, W., Tian, L., Xu, J., Li, Z., & Wang, T. (2025) · Cancer Management and Research · doi:10.2147/cmar.s506630 · Cited by 12
Personalized test tracks cancer relapse
Bardelli, A. (2017) · Nature · doi:10.1038/545417a · Cited by 11
Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study
Chen, K., Zhao, H., Yang, F., Hui, B., Wang, T., Wang, L. T., Shi, Y., & Wang, J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019012 · Cited by 11
The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal Cancer
Xie, H., & Kim, R. D. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09002-7 · Cited by 11
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives
Merk, C., Martling, A., Lindberg, J., Benhaïm, L., Taı̈eb, J., & Lind, P. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2033831 · Cited by 11
Molecular markers in cancer
Ahmad, E., Ali, A., Nimisha, Sharma, A. K., Apurva, A., Kumar, A., Dar, G. M., Sattar, R. S. A., Verma, R., Mahajan, B., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.029 · Cited by 11
Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer
Chen, L., Zhou, W., Ye, Z., Zhong, X., Zhou, J., Chen, S., Liu, W., Sun, Y., Ren, L., Tan, X., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08560 · Cited by 11
Longitudinal ctDNA profiling in precision oncology and immunο-oncology
Filis, P., Kyrochristos, I. D., Korakaki, E., Baltagiannis, E. G., Thanos, D., & Roukos, D. H. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103540 · Cited by 12
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report
Calapre, L., Warburton, L., Millward, M., & Gray, E. S. (2019) · BMC Cancer · doi:10.1186/s12885-019-6336-3 · Cited by 11
Future perspectives from lung cancer pre-clinical models: new treatments are coming?
Bersani, F., Morena, D., Picca, F., Morotti, A., Tabbò, F., Bironzo, P., Righi, L., & Taulli, R. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-189 · Cited by 10
A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study
Fan, J., Liu, Y., Cai, X., Wang, J., Guo, R., Ji, Y., Li, C., Xu, Y., Li, X., Zhang, C., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566784 · Cited by 14
Targeted Therapy in Early Stage Non-small Cell Lung Cancer
Liu, S., Liu, S. M., Zhong, W., & Wu, Y.-L. L. C. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00994-w · Cited by 12
Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
Chan, R., Lin, P., Chen, S., Lin, S.-C., Chen, P.-C., Lin, B., Shen, M., & Yeh, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.589673 · Cited by 11
Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non–small cell lung cancer
Isbell, J. M., Jones, D. R., & Li, B. T. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.12.157 · Cited by 11
Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases
Chen, Z., Ji, X., Xu, Y., Fong, W. P., Liu, X., Liang, J., Tan, Q., Wen, L., Cai, Y., Wang, D., et al. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241230752 · Cited by 11
Liquid biopsy for monitoring minimal residual disease in colorectal cancer: A promising approach with clinical implications
Wang, Z., Bai, J., Jiang, D., Li, Y., Hu, X., Efetov, S. K., Cao, Y., Kayaalp, C., Dulskas, A., Shaw, D. D., et al. (2024) · Clinical Surgical Oncology · doi:10.1016/j.cson.2024.100056 · Cited by 10
The clinical utility of circulating human papillomavirus across squamous cell carcinomas
Spindler, K. G., Jakobsen, A. V., Eriksen, J. G., Fokdal, L. U., Nordsmark, M., Thorsen, L. B. J., Wind, K. L., Lefèvre, A. C., & Overgaard, J. (2025) · Acta Oncologica · doi:10.2340/1651-226x.2025.41288 · Cited by 10
GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patients
Broche, J., Kelemen, O., Aishwarya, S., Schütz, L., Muyas, F., Forschner, A., Schroeder, C., & Ossowski, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06993-3 · Cited by 10
Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis
Khan, A. U., Jasim, Y. H., Shahid, K., Baxtiyorovich, S. J., Atamuratova, Z., & Urazbaeva, D. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04073-y · Cited by 11
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment
Kitagawa, Y., Okumura, K., Watanabe, T., Tsukamoto, K., Kitano, S., Nankinzan, R., Suzuki, T., Hara, T., Soda, H., Denda, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47700-9 · Cited by 10
Developing more sensitive genomic approaches to detect radioresponse in precision radiation oncology: From tissue DNA analysis to circulating tumor DNA
He, K., Zhang, S., Shao, L. L., Yin, J. C., Wu, X., Shao, Y. W., Yuan, S., & Yu, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.004 · Cited by 9
Utility of Circulating Tumor Cells and DNA in the Management of Advanced Colorectal Cancer
Pan, X., & Zhang, X. (2020) · Future Oncology · doi:10.2217/fon-2020-0073 · Cited by 10
Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Jones, J., Cain, S. A., Pešić-Smith, J. D., Choong, P., Morokoff, A. P., Drummond, K. J., & Dabscheck, G. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03846-z · Cited by 10
Liquid Biopsies for Molecular Biology-Based Radiotherapy
Blomain, E. S., & Moding, E. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011267 · Cited by 10
cfTrack : A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution
Li, S., Zeng, W., Ni, X., Zhou, Y., Stackpole, M. L., Noor, Z. S., Yuan, Z., Neal, A., Memarzadeh, S., Garon, E. B., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1242 · Cited by 10
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL
Kumbrink, J., Bohlmann, L., Mamlouk, S., Redmer, T., Peilstöcker, D., Li, P., Lorenzen, S., Algül, H., Kasper, S., Hempel, D., et al. (2022) · Cancers · doi:10.3390/cancers14153631 · Cited by 10
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
Vasconcelos, J. P. S., Boutin, M., & Loree, J. M. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221143975 · Cited by 11
Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA
Zhang, X., Zhang, Y., Zhang, S., Wang, S., Yang, P., & Liu, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1098128 · Cited by 10
Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients
Wollison, B. M., Thai, E., McKinney, A., Ward, A., Clapp, A. N., Clinton, C., Nag, A., Thorner, A. R., Gastier, J. M., & Crompton, B. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188835 · Cited by 10
A Highly Verified Assay for KRAS Mutation Detection in Tissue and Plasma of Lung, Colorectal, and Pancreatic Cancer
Li, J., Gan, S., Blair, A., Min, K., Rehage, T., Hoeppner, C., Halait, H., & Brophy, V. H. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0471-oa · Cited by 10
Circulating Tumor DNA: Clinical Monitoring and Early Detection
Corcoran, R. B. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055719 · Cited by 10
Circulating tumor DNA and their added value in molecular oncology
Leers, M. P. G. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0436 · Cited by 12
Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model
Eun, Y., YOON, Y. J., Won, K. Y., & Lee, Y. C. (2019) · Anticancer Research · doi:10.21873/anticanres.13940 · Cited by 10
Circulating Tumour DNAs and Non-Coding RNAs as Liquid Biopsies for the Management of Colorectal Cancer Patients
Lampis, A., Ghidini, M., Ratti, M., Mirchev, M. B., Okuducu, A. F., Valeri, N., & Hahne, J. C. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2030022 · Cited by 10
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
Lim, A. M. L., Cavanagh, K., Hicks, R. J., McLean, L. S., Goh, M., Webb, A., & Rischin, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656611 · Cited by 10
A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification
Goh, S. K., Cox, D. R. A., Wong, B. K. L., Musafer, A., Witkowski, T., Do, H., Muralidharan, V., & Dobrovic, A. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab095 · Cited by 10
Emerging Strategies in the Initial Management of Locally Advanced Rectal Cancer
Gately, L., Wong, H., Tie, J., Wong, R., Lee, M., Lee, B., Jalali, A., & Gibbs, P. (2019) · Future Oncology · doi:10.2217/fon-2018-0941 · Cited by 10
Self-citation
Polarization-Sensitive Optical Coherence Tomography for Renal Tumor Detection in Ex Vivo Human Kidneys
Yan, F., Wang, C., Yan, Y., Zhang, Q., Yu, Z., Patel, S., Fung, K.-M. A., & Tang, Q. (2023) · Optics and Lasers in Engineering · doi:10.1016/j.optlaseng.2023.107900 · Cited by 9
Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancer
Kim, S. H., & Weigelt, B. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101431 · Cited by 9
Cervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?
Antonouli, S., Nisio, V. D., Daponte, N., Daponte, A., & Daponte, A. (2024) · Biomolecules · doi:10.3390/biom14070825 · Cited by 9
Circulating tumor DNA in colorectal cancer: biology, methods and applications
Chen, H., An, Y., Wang, C., & Zhou, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02220-z · Cited by 10
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial
Nasca, V., Bergamo, F., Foltran, L., Antonuzzo, L., Bencardino, K. B., Dell’Aquila, E., Corallo, S., Spallanzani, A., Brunetti, O., Spada, D., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14063-6 · Cited by 11
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives
Martelli, V., Vidal, J., Salvans, S., Fernández‐Rodríguez, C., Badia-Ramentol, J., Linares, J., Jiménez‐Toscano, M., Sibilio, A., Gibert, J., Pérez, M., et al. (2025) · Cancers · doi:10.3390/cancers17091461 · Cited by 9
Circulating tumor DNA in biliary tract cancers: A review of current applications
Teixeira, M. F., Borad, M. J., & Usón, P. L. S. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.107875 · Cited by 9
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer
Wang, Y., Xiang, Y., Chen, X.-W., Zhang, T., Wang, J.-Y., Liu, W.-Y., Deng, L., Wang, L.-H., Gao, S., & Bi, N. (2026) · Military Medical Research · doi:10.1186/s40779-025-00679-z · Cited by 9
Self-citation
Immunoscore—has it scored for colon cancer precision medicine?
Jorissen, R. N., Sakthianandeswaren, A., & Sieber, O. M. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.09.29 · Cited by 9
Future directions and management of liquid biopsy in non-small cell lung cancer
Cossu, A. M., Scrima, M., Lombardi, A., Grimaldi, A., Russo, M., Ottaiano, A., Caraglia, M., & Bocchetti, M. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00015 · Cited by 9
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA
Labgaa, I., von Felden, J., Craig, A. J., Martins-Filho, S. N., Villacorta-Martín, C., Demartines, N., Dormond, O., D’Avola, D., & Villanueva, A. (2021) · Hepatology Communications · doi:10.1002/hep4.1692 · Cited by 9
Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy
Li, M., Xie, S., Lu, C., Zhu, L., & Zhu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692322 · Cited by 9
Circulating DNA in the neoadjuvant setting of early stage colon cancer
Bregni, G., Pretta, A., Senti, C., Reina, E. A., Vandeputte, C., Trevisi, E., Gkolfakis, P., Kehagias, P., Deleporte, A., Laethem, J. V., et al. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2101023 · Cited by 10
Roles of circulating tumor DNA in PD-1/PD-L1 immune checkpoint Inhibitors: Current evidence and future directions
Liu, Z., Han, Y., Dang, Q., Xu, H., Zhang, Y., Duo, M., Lv, J., Li, H., Kong, Y., & Han, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109173 · Cited by 9
PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance
Parisi, E., Hidalgo, I., Montal, R., Pallisé, O., Tarragona, J., Sorolla, A., Novell, A., Campbell, K., Sorolla, M. A., Casali, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310889 · Cited by 8
PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study
Mihara, Y., Hirasaki, M., Horita, Y., Fujino, T., Fukushima, H., Kamakura, Y., Uranishi, K., Hirano, Y., Ryozawa, S., Yasuda, M., et al. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02975-1 · Cited by 9
Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients
de Moraes, F. C. A., Kelly, F. A., Souza, M. E. C., & Burbano, R. M. R. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04668-x · Cited by 10
Personalized Adjuvant Treatment of Colon Cancer
Taghizadeh, H., & Prager, G. W. (2020) · Visceral Medicine · doi:10.1159/000508175 · Cited by 10
Twelve-Week Yoga vs. Aerobic Cycling Initiation in Sedentary Healthy Subjects: A Behavioral and Multiparametric Interventional PET/MR Study
van Aalst, J., Jennen, L., Demyttenaere, K., Sunaert, S. G., Koole, M. J. B., Ceccarini, J., & Laere, K. V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.739356 · Cited by 10
Liquid biopsies for colorectal cancer: a narrative review of ongoing clinical trials and the current use of this technology at a comprehensive cancer center
Broccard, S. P., Kasbi, A. A., Bagaria, S. P., Jones, J. C., Shoukry, M. M., & Gabriel, E. M. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-470 · Cited by 8
Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
Piercey, O., & Tie, J. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231160138 · Cited by 9
Self-citation
Prognostic and Predictive Markers for Patients With Anal Cancer
Holliday, E. B., Peddireddy, A. S., & Morris, V. K. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.7031 · Cited by 9
Circulating biomarkers to guide systemic therapy for urothelial carcinoma
Abbosh, P. H., Rosenberg, J. E., & Plimack, E. R. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.08.019 · Cited by 9
Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancer
Tabbò, F., & Novello, S. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.07.07 · Cited by 8
Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas
Yang, C., Tan, Y., Li, S., Zhou, J., Wang, Q., Wang, Y., Xie, Y., Chen, L., Li, J., Fang, C., et al. (2019) · Aging · doi:10.18632/aging.102526 · Cited by 11
Self-citation
Grainyhead-Like Genes Family May Act as Novel Biomarkers in Colon Cancer
Yuan, M., Wang, J., & Fang, F. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s242763 · Cited by 9
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
Internò, V., Tucci, M., Pezzicoli, G., Silvestris, F., Porta, C., & Mannavola, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581130 · Cited by 9
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies
Zhang, S., Brazel, D., Kumar, P., Schafer, L. N., Eidenschink, B., Senthil, M., & Dayyani, F. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-484 · Cited by 9
Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer
Abbosh, C., Swanton, C., & Birkbak, N. J. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy017 · Cited by 8
Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC
Wu, C. S.-Y., Pai, R. K., Kosiorek, H., Banerjee, I., Pfeiffer, A., Hagen, C. E., Hartley, C., Graham, R. P., Sonbol, M. B., Bekaii‐Saab, T., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3211 · Cited by 9
Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities
Trevisi, E., Sessa, C., & Colombo, I. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00239 · Cited by 8
Characteristics of Gut Microbiota and Fecal Metabolites in Patients with Colorectal Cancer-Associated Iron Deficiency Anemia
Zhang, Q., Wu, W., Guo, F., Li, J., Jin, Y., Cai, G., & Yang, Y. (2024) · Microorganisms · doi:10.3390/microorganisms12071319 · Cited by 8
Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer
Kourié, H. R., Zouein, J., Zalaquett, Z., Chebly, A., Nasr, L. F., Karak, F. E., Sadek, M., Safar, O., Fouani, M., Bitar, N., et al. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102417 · Cited by 8
Metastatic hormone-naïve prostate cancer: a distinct biological entity
Corres-Mendizabal, J., Zacchi, F., Martín-Martín, N., Mateo, J., & Carracedo, A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.06.005 · Cited by 8
Circulating tumor DNA as a biomarker of prognosis prediction in colorectal cancer: a systematic review and meta‐analysis
Zhou, Q., Chen, X., Zeng, B., Zhang, M., Guo, N., Wu, S., Zeng, H., & Sun, F. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.05.007 · Cited by 10
Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
Liu, Z., Shi, Z., Jiang, W., Shen, Z., Chen, W., Shen, K., Yihong, S., Tang, Z., & Wang, X. (2025) · MedComm · doi:10.1002/mco2.70065 · Cited by 8
Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer
Kawashima, M., Yamada, T., Miyasaka, T., Kanaka, S., Kuriyama, S., Uehara, K., Matsuda, A., Ohta, R., Sonoda, H., Taniai, N., et al. (2025) · Cancer Science · doi:10.1111/cas.16442 · Cited by 10
Cell‐free DNA for detection and monitoring of extramedullary AML relapse
Hupe, H. C., Wienecke, C. P., Bartels, S., Schipper, E., Leßmann, J., Lasch, A., Bader, M., Gabdoulline, R. R., Neugebohren, M., Dammann, E., et al. (2025) · HemaSphere · doi:10.1002/hem3.70097 · Cited by 9
Efficacy and safety of oxaliplatin-based chemotherapy as first-line treatment in elderly patients with metastatic colorectal cancer: a meta-analysis
Fan, S., Zhao, Z., Wang, H., Wang, H., & Niu, W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1567732 · Cited by 8
Minimum Technical Preanalytical, Patient, and Clinical Context Data Elements for Cerebrospinal Fluid Liquid Biopsy: Recommendations for Public Database Submissions
Bagley, S. J., Beaubier, N. T., Balaj, L., Bettegowda, C., Carpenter, E. L., Carter, B. S., Corner, A. S., Dittamore, R. V., Grossman, R. L., Hickman, R. A., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00921 · Cited by 8
Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer
Lakbir, S., Lahoz, S., Cuatrecasas, M., Camps, J., Glas, R. A., Heringa, J., Meijer, G. A., Abeln, S., & Fijneman, R. J. A. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.034 · Cited by 11
Noninvasive genomic profiling of somatic mutations in oral cavity cancers
Xi, Y., Negrao, M. V., Akagi, K., Xiao, W., Jiang, B., Warner, S. C., Dunn, J. D., Wang, J., Symer, D. E., & Gillison, M. L. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106372 · Cited by 8
Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study
Hanna, L., Sellahewa, R., Huggins, C. E., Lundy, J., & Croagh, D. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-36643-x · Cited by 8
Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta‐analysis
Mi, J., Wang, R., Han, X., Ma, R.-J., & Zhao, D. (2023) · Cancer Medicine · doi:10.1002/cam4.6434 · Cited by 6
Clinical trial and real-world evidence of circulating tumor DNA monitoring to predict recurrence in patients with resected colorectal cancer
Nguyen, H. T., Hoang, V.-T.-L., Nguyen, T. V., Trinh, N. A. L., Pham, T. H., Le, D. N., Ho, H. H., Nguyen, T. D., Nguyen, H. D., Do, T. T., et al. (2024) · ESMO Real World Data and Digital Oncology · doi:10.1016/j.esmorw.2024.100076 · Cited by 9
Circulating tumor DNA: A new tool to predict recurrence and guide treatment of colorectal cancer
Quang, E. V., Gandini, A., Taly, V., Laurent‐Puig, P., Zaanan, A., & Taı̈eb, J. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102611 · Cited by 9
Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker
Christie, E. L., Dawson, S., & Bowtell, D. D. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2281 · Cited by 8
Improving Cancer Detection and Treatment with Liquid Biopsies and ptDNA
Kessler, M. D., Pawar, N. R., Martin, S. S., Antalis, T., & O’Connor, T. D. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.07.004 · Cited by 9
The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
Kosovec, J. E., Zaidi, A. H., Pounardjian, T., & Jobe, B. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00610 · Cited by 8
Cell-Free DNA in the Management of Colorectal Cancer
Harlé, A. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-26439-0_13 · Cited by 8
Comparison of Somatic Mutation Profiles Between Formalin-Fixed Paraffin Embedded Tissues and Plasma Cell-Free DNA from Ovarian Cancer Patients Before and After Surgery
Jagelková, M., Zelinová, K., Laučeková, Z., Bobrovská, M., Daňková, Z., Grendár, M., & Dókuš, K. (2020) · BioResearch open access · doi:10.1089/biores.2019.0031 · Cited by 8
Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy
Vierstraete, J., Fieuws, C., Willaert, A., Vral, A., & Claes, K. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.103023 · Cited by 8
Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study
Behrenbruch, C., Prabhakaran, S., Udayasiri, D. K., Hollande, F., Michael, M., Hayes, I., Heriot, A. G., Knowles, B., & Thomson, B. N. J. (2021) · ANZ Journal of Surgery · doi:10.1111/ans.16613 · Cited by 8
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey
Basile, D., Gallois, C., Puglisi, F., Cohen, R., Goèré, D., Aprile, G., Lepage, C., Laurent‐Puig, P., Maïo, M. D., Lecomte, T., et al. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101681 · Cited by 8
Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review
Hsu, P. J., Singh, K., Dhiman, A., Witmer, H. D. D., He, C., Eng, O. S., Catenacci, D. V. T., Posner, M. C., & Turaga, K. K. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00337 · Cited by 8
Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia
Barsan, V. V., Xia, Y., Klein, D., Gonzalez-Pena, V., Youssef, S. H., Inaba, Y., Mahmud, O., Natarajan, S., Agarwal, V., Pang, Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj1360 · Cited by 8
Circulating tumor DNA-minimal residual disease: An up-and-coming nova in resectable non-small-cell lung cancer
Li, F., & Cui, J. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103800 · Cited by 8
Accurate measurement of microsatellite length by disrupting its tandem repeat structure
Wang, Z., Moffitt, A. B., Andrews, P., Wigler, M. H., & Levy, D. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac723 · Cited by 8
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation
Watanabe, K., Saito, R., Miyauchi, E., Nagashima, H., Nakamura, A., Sugawara, S., Tanaka, N., Terasaki, H., Fukuhara, T., & Maemondo, M. (2023) · Cancers · doi:10.3390/cancers15174231 · Cited by 8
The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
Sawada, K., Kotani, D., & Bando, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00263 · Cited by 8
Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data
Huang, K., Qu, H., Zhang, X., Huang, T., Sun, X., He, W., Li, M., Lin, L., Xu, M., Chen, S., et al. (2019) · Cancer Biomarkers · doi:10.3233/cbm-190257 · Cited by 8

Authors: Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., Kosmider, S., Skinner, I., Wong, R., Steel, M., Tran, B., Desai, J., Jones, I., Haydon, A., Hayes, T., Price, T. J., Strausberg, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Gibbs, P.
Affiliations: The University of Melbourne (AU)
Howard Hughes Medical Institute (US)
Johns Hopkins University (US)
PapGene (United States) (US)
The Royal Melbourne Hospital (AU)
Western Health (AU)
Walter and Eliza Hall Institute of Medical Research (AU)
Eastern Health (AU)
The Alfred Hospital (AU)
Department of Medical Oncology, Warrnambool Hospital, Warrnambool, Victoria 3280, Australia.
Department of Medical Oncology, Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia 3174, Australia.
Ludwig Cancer Research (US)
Corresponding author: Tie, Jeanne
Wang, Yuxuan
Vogelstein, Bert
Gibbs, Peter
ORCID: Tie, Jeanne
Wang, Yuxuan
Tomasetti, Cristian
Li, Lu
Springer, Simeon
Silliman, Natalie
Tacey, Mark
Wong, Hui-Li
Christie, Michael
Kosmider, Suzanne
Skinner, Iain
Wong, Rachel
Steel, Malcolm
Tran, Ben
Desai, Jayesh
Jones, Ian
Haydon, Andrew
Hayes, Theresa
Diaz, Luis A.
Papadopoulos, Nickolas
Kinzler, Kenneth W.
Vogelstein, Bert
Gibbs, Peter
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2016-07-06
Volume: 8
Issue: 346
Pages: 346ra92-346ra92
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.aaf6219
PMC: PMC5346159
OpenAlex: W2460179076
Cited by: 1,492
References: 43
Citations by year: 2026: 119 · 2025: 131 · 2024: 130 · 2023: 181 · 2022: 173 · 2021: 197 · 2020: 173 · 2019: 146 · 2018: 134 · 2017: 90 · 2016: 14
FWCI: 53.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.sciencemag.org/about/science-licenses-journal-article-reuse (vor, 365 d)
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders: Virginia and D.K. Ludwig Fund for Cancer Research
Conrad N. Hilton Foundation
Sol Goldman Sequencing Facility at Johns Hopkins
NIH (CA57345, R37-CA43460, U01-CA152753, P30-CA006973)
Victorian Cancer Agency
Victorian Cancer Agency Clinical Research Fellowship
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords: circulating tumor DNA, stage II colon cancer, minimal residual disease, tumor recurrence prediction, adjuvant chemotherapy, liquid biopsy, recurrence-free survival, plasma biomarkers, resected colon cancer
MeSH terms: Circulating Tumor DNA, Colonic Neoplasms, Humans, Neoplasm Recurrence, Local, Neoplasm Staging, Prospective Studies, Proportional Hazards Models, Neoplasm, Residual, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks